Parallel Phase III Randomized Trials for High Risk Prostate Cancer Evaluating De-Intensification for Lower Genomic Risk and Intensification of Concurrent Therapy for Higher Genomic Risk with Radiation (PREDICT-RT*)
Eligible for screening study DCP 001
Closure of Accrual for QOL Substudy for pateints enrolled in Arms 1 and 2, effective September 22, 2023
Optional Imaging Sub Study is temporarily closed accrual, effective December 21, 2021
